STOCK TITAN

Castle Biosciences director gifts 5,985 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Castle Biosciences director Daniel Bradbury reported a 5,985-share bona fide gift for no consideration on November 17, 2026, to a charitable donor advised fund. Bradbury retained no voting, investment, or pecuniary interest in the gifted shares. The reported post-transaction position was 29,646 shares held by The Bradbury Family Trust; a footnote says this reflects a transfer of 22,340 shares from direct holdings to the trust.

Insider BRADBURY DANIEL
Role Director
Type Security Shares Price Value
Gift Common Stock F1, F2, F3 5,985 $0.00 $0.00
Holdings After Transaction: Common Stock — 29,646 shares (Indirect, The Bradbury Family Trust)
Holdings Before and After: Common Stock, 35,631 to 29,646 shares (Indirect, The Bradbury Family Trust)
Footnotes (3)
  1. F1. Represents a bona fide gift by the Reporting Person, for no consideration, to a charitable donor advised fund. The Reporting Person retains no voting, investment, or pecuniary interest in the gifted shares.
  2. F2. Reflects the November 17, 2026 transfer of 22,340 shares from their direct holdings to The Bradbury Family Trust.
  3. F3. Held by Bradbury Family Trust of which the Reporting Person and Annette Bradbury are the trustees and the beneficiaries.
Shares gifted 5,985 shares Gift to a charitable donor advised fund on November 17, 2026
Trust shares after transaction 29,646 shares Held by The Bradbury Family Trust after the reported transaction
Shares transferred to trust 22,340 shares Transfer from direct holdings to The Bradbury Family Trust on November 17, 2026
donor advised fund financial
"to a charitable donor advised fund"
A donor advised fund is a charitable savings account you fund with cash or assets (including stocks) that lets you take an immediate tax benefit while recommending when and which charities receive grants over time. Think of it like a dedicated piggy bank for giving: you get tax relief when you put money in, can avoid selling appreciated securities and triggering capital gains, and still control the timing and recipients of donations, which affects tax planning, portfolio decisions, and public giving signals.
pecuniary interest regulatory
"no voting, investment, or pecuniary interest in the gifted shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CSTL shares did Daniel Bradbury give to charity?

Daniel Bradbury, a director of Castle Biosciences, reported a gift of 5,985 shares for no consideration to a charitable donor advised fund on November 17, 2026.

Who are the trustees and beneficiaries of CSTL director Daniel Bradbury's family trust?

Daniel Bradbury and Annette Bradbury are the trustees and beneficiaries of The Bradbury Family Trust.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BRADBURY DANIEL

(Last)(First)(Middle)
C/O CASTLE BIOSCIENCES, INC.
1500 W. PARKWOOD AVE SUITE 400

(Street)
FRIENDSWOOD TEXAS 77546

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CASTLE BIOSCIENCES INC [ CSTL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/17/2026G5,985(1)D$029,646(2)IThe Bradbury Family Trust(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents a bona fide gift by the Reporting Person, for no consideration, to a charitable donor advised fund. The Reporting Person retains no voting, investment, or pecuniary interest in the gifted shares.
2. Reflects the November 17, 2026 transfer of 22,340 shares from their direct holdings to The Bradbury Family Trust.
3. Held by Bradbury Family Trust of which the Reporting Person and Annette Bradbury are the trustees and the beneficiaries.
Remarks:
/s/ Frank Stokes, Attorney-in-fact11/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading